The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $19.5 million in the period, which also beat ...
News
- Xencor: 2Q Earnings Snapshot
- Capricor: 2Q Earnings Snapshot
The biotechnology company posted revenue of $410,400 in the period. Its adjusted revenue was $410,000. In the final minutes of trading on Tuesday, ...
- Enanta Pharmaceuticals: Fiscal 3Q Earnings Snapshot
The biotechnology company posted revenue of $44.4 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $46.3 ...
- Eastside Life Science Hub VelocityTX on Track for September Launch
A life sciences innovation hub in East San Antonio is on pace to open next month, officials said. VelocityTX, an incubator and business complex for life ...
- APOE variants' effect on mortality studied in 38000
The findings by the E2-CHARGE consortium of investigators, led by senior investigator Sudha Seshadri, M.D., of UT Health San Antonio, suggest new ...